Position in NGNE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$9,295,393
+$1,581,230 QoQ
Shares Held
295,561
-22.8% QoQ
Ownership
1.48%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 111 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NGNE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,424,667,384 across 370 Biotechnology names. NGNE ranks #161 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in NGNE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,295,393 | 295,561 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $7,714,163 | 382,647 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,684,777 | 130,329 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,002,481 | 115,550 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $7,003,715 | 468,476 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,420,312 | 462,879 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $19,667,211 | 860,333 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $30,706,369 | 731,801 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,630,487 | 72,286 | Shares | Defined | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||